153 related articles for article (PubMed ID: 11548209)
1. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
Wang QM
Prog Drug Res; 2001; Spec No():229-53. PubMed ID: 11548209
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
Wang QM
Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129
[TBL] [Abstract][Full Text] [Related]
3. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
Wanga QM; Chen SH
Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
[TBL] [Abstract][Full Text] [Related]
4. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
Wang HM; Liang PH
Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
[TBL] [Abstract][Full Text] [Related]
5. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
Ramajayam R; Tan KP; Liang PH
Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of 3C cysteine proteinases from Picornaviridae.
Lall MS; Jain RP; Vederas JC
Curr Top Med Chem; 2004; 4(12):1239-53. PubMed ID: 15320724
[TBL] [Abstract][Full Text] [Related]
7. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
[TBL] [Abstract][Full Text] [Related]
8. [Current research on picornavirus 3C protease].
Wang H; Xie GC; Duan ZJ
Bing Du Xue Bao; 2014 Sep; 30(5):579-86. PubMed ID: 25562970
[TBL] [Abstract][Full Text] [Related]
9. Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.
Sun D; Chen S; Cheng A; Wang M
Viruses; 2016 Mar; 8(3):82. PubMed ID: 26999188
[TBL] [Abstract][Full Text] [Related]
10. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
[TBL] [Abstract][Full Text] [Related]
12. Toward development of generic inhibitors against the 3C proteases of picornaviruses.
Banerjee K; Bhat R; Rao VUB; Nain A; Rallapalli KL; Gangopadhyay S; Singh RP; Banerjee M; Jayaram B
FEBS J; 2019 Feb; 286(4):765-787. PubMed ID: 30461192
[TBL] [Abstract][Full Text] [Related]
13. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
[TBL] [Abstract][Full Text] [Related]
14. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
[TBL] [Abstract][Full Text] [Related]
15. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of picornavirus replication.
De Palma AM; Vliegen I; De Clercq E; Neyts J
Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
[TBL] [Abstract][Full Text] [Related]
17. Non-covalent inhibitors of rhinovirus 3C protease.
Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
19. Proteases of human rhinovirus: role in infection.
Jensen LM; Walker EJ; Jans DA; Ghildyal R
Methods Mol Biol; 2015; 1221():129-41. PubMed ID: 25261311
[TBL] [Abstract][Full Text] [Related]
20. Structural and mechanistic aspects of 3C proteases from the Picornavirus family.
Arad D; Kreisberg R; Shokhen M
J Chem Inf Comput Sci; 1993; 33(3):345-9. PubMed ID: 8320292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
